Unknown PHASE4 INTERVENTIONAL 2-arm NCT00633685

Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure

Sponsor: C.R.Darnall Army Medical Center

Conditions Posttraumatic Stress Disorder, Combat-related

Updated 7 times since 2017 Last updated: May 24, 2010 Started: Mar 31, 2010 Primary completion: Jun 30, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Posttraumatic Stress Disorder, Combat-related, this trial is ongoing. The trial is conducted by C.R.Darnall Army Medical Center and has accumulated 7 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

C.R.Darnall Army Medical Center
Central Texas Veterans Health Care System
TEMPVA Research Group, Inc.
VA Boston Healthcare System

Data source: TEMPVA Research Group, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Hood, United States